Molecular Cancer Therapeutics

Trans,trans,trans-[PtIV(N3)2(OH)2(py)(NH3)]: A Light-Activated Antitumor Platinum Complex That Kills Human Cancer Cells by an Apoptosis-Independent Mechanism

Westendorf, A. F., Woods, J. A., Korpis, K., Farrer, N. J., Salassa, L., Robinson, K., Appleyard, V., Murray, K., Grünert, R., Thompson, A. M., Sadler, P. J. & Bednarski, P. J. 2012 In : Molecular Cancer Therapeutics. 11, 9, p. 1894-1904, 11 p.

Research output: Contribution to journal › Article

Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator

Lain, S., Hollick, J., Campbell, J., Staples, O. D., Higgins, M., Aoubala, M., McCarthy, A., Appleyard, V., Murray, K., Thompson, A., Mathers, J., Holland, S., Stark, M. J. R., Lane, D. & Westwood, N. J. Dec-2007 In : Molecular Cancer Therapeutics. 6, 12, p. 3476S-3477S, 2 p.

Research output: Contribution to journal › Book/Film/Article review

Synthesis and biological properties of bioreductively targeted nitrothienyl prodrugs of combretastatin A-4

Thomson, P., Naylor, M. A., Everett, S. A., Stratford, M. R. L., Lewis, G., Hill, S., Patel, K. B., Wardman, P. & Davis, P. D. Nov-2006 In : Molecular Cancer Therapeutics. 5, 11, p. 2886-2894, 9 p.

Research output: Contribution to journal › Article